Search
Ocular Therapeutix Inc
OCULAdd to Watchlist
8.630USD
+0.125+1.47%
Close 07-27 16:00（ET）Quotes delayed by 15 min
1.51BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-27The current earnings forecast score of Ocular Therapeutix Inc is 8.67, ranking 12 out of 155 in the Pharmaceuticals industry. The average price target is 22.50, with a high of 31.00 and a low of 18.00.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
26.727
Target Price
+214.25%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Ocular Therapeutix Inc
OCUL
12
Biogen Inc
BIIB
38
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Ocular Therapeutix Inc's expected revenue for the next quarter?
Ocular Therapeutix Inc's expected revenue is 13.20M.
What is Ocular Therapeutix Inc's price target?
Analysts forecast that Ocular Therapeutix Inc's price target is USD 22.50, with the highest forecast at USD 31.00 and the lowest forecast at USD 18.00.
How have Ocular Therapeutix IncOCUL's recent earnings per share performed?
The market expectation was USD -0.40, while Ocular Therapeutix IncOCUL's earnings per share (EPS) for the previous quarter was USD -0.29. EPS for the next quarter is expected at USD -0.40.
What is the analyst rating for Ocular Therapeutix Inc?
Based on the ratings of Ocular Therapeutix Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.